A Rollover Protocol to Allow Continued Access to Tivozanib (AV 951) for Subjects Enrolled in Other Tivozanib Protocols
Clinical trial NCT01369433 · TERMINATED
Trial details
- NCT number
- NCT01369433
- Sponsor
- AVEO Pharmaceuticals, Inc.
- Status
- TERMINATED
- Phase
- Not Applicable
- Study type
- INTERVENTIONAL
- Start date
- 2010-06-01
- Primary completion
- 2015-06-01
- Enrollment
- 225
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.